These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35598856)

  • 1. Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis.
    Lee TC; Murthy S; Del Corpo O; Senécal J; Butler-Laporte G; Sohani ZN; Brophy JM; McDonald EG
    Clin Microbiol Infect; 2022 Sep; 28(9):1203-1210. PubMed ID: 35598856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remdesivir for the treatment of COVID-19.
    Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014962. PubMed ID: 34350582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis.
    Lee TC; McDonald EG; Butler-Laporte G; Harrison LB; Cheng MP; Brophy JM
    Int J Infect Dis; 2021 Mar; 104():671-676. PubMed ID: 33540128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.
    Kalil AC; Mehta AK; Patterson TF; Erdmann N; Gomez CA; Jain MK; Wolfe CR; Ruiz-Palacios GM; Kline S; Regalado Pineda J; Luetkemeyer AF; Harkins MS; Jackson PEH; Iovine NM; Tapson VF; Oh MD; Whitaker JA; Mularski RA; Paules CI; Ince D; Takasaki J; Sweeney DA; Sandkovsky U; Wyles DL; Hohmann E; Grimes KA; Grossberg R; Laguio-Vila M; Lambert AA; Lopez de Castilla D; Kim E; Larson L; Wan CR; Traenkner JJ; Ponce PO; Patterson JE; Goepfert PA; Sofarelli TA; Mocherla S; Ko ER; Ponce de Leon A; Doernberg SB; Atmar RL; Maves RC; Dangond F; Ferreira J; Green M; Makowski M; Bonnett T; Beresnev T; Ghazaryan V; Dempsey W; Nayak SU; Dodd L; Tomashek KM; Beigel JH;
    Lancet Respir Med; 2021 Dec; 9(12):1365-1376. PubMed ID: 34672949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major Update: Remdesivir for Adults With COVID-19 : A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points.
    Kaka AS; MacDonald R; Greer N; Vela K; Duan-Porter W; Obley A; Wilt TJ
    Ann Intern Med; 2021 May; 174(5):663-672. PubMed ID: 33560863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remdesivir for the treatment of COVID-19.
    Grundeis F; Ansems K; Dahms K; Thieme V; Metzendorf MI; Skoetz N; Benstoem C; Mikolajewska A; Griesel M; Fichtner F; Stegemann M
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014962. PubMed ID: 36695483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
    Ader F; Bouscambert-Duchamp M; Hites M; Peiffer-Smadja N; Poissy J; Belhadi D; Diallo A; Lê MP; Peytavin G; Staub T; Greil R; Guedj J; Paiva JA; Costagliola D; Yazdanpanah Y; Burdet C; Mentré F;
    Lancet Infect Dis; 2022 Feb; 22(2):209-221. PubMed ID: 34534511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir for Adults With COVID-19 : A Living Systematic Review for American College of Physicians Practice Points.
    Wilt TJ; Kaka AS; MacDonald R; Greer N; Obley A; Duan-Porter W
    Ann Intern Med; 2021 Feb; 174(2):209-220. PubMed ID: 33017170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    Juul S; Nielsen EE; Feinberg J; Siddiqui F; Jørgensen CK; Barot E; Holgersson J; Nielsen N; Bentzer P; Veroniki AA; Thabane L; Bu F; Klingenberg S; Gluud C; Jakobsen JC
    PLoS One; 2021; 16(3):e0248132. PubMed ID: 33705495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of remdesivir on mortality and the requirement for mechanical ventilation in patients with COVID-19: a systematic review stratified by disease severity.
    Ryoo S; Choi M; Yu SY; Yoon YK; Huh K; Joo EJ
    Korean J Intern Med; 2024 Jan; 39(1):160-171. PubMed ID: 38151918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis.
    Angamo MT; Mohammed MA; Peterson GM
    Infection; 2022 Feb; 50(1):27-41. PubMed ID: 34331674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remdesivir Treatment Lacks the Effect on Mortality Reduction in Hospitalized Adult COVID-19 Patients Who Required High-Flow Supplemental Oxygen or Invasive Mechanical Ventilation.
    Huang C; Lu TL; Lin L
    Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374231
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis.
    Piscoya A; Ng-Sueng LF; Parra Del Riego A; Cerna-Viacava R; Pasupuleti V; Roman YM; Thota P; White CM; Hernandez AV
    PLoS One; 2020; 15(12):e0243705. PubMed ID: 33301514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
    Kim MS; An MH; Kim WJ; Hwang TH
    PLoS Med; 2020 Dec; 17(12):e1003501. PubMed ID: 33378357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of remdesivir in patients with COVID-19: a systematic review and meta-analysis.
    Tanni SE; Silvinato A; Floriano I; Bacha HA; Barbosa AN; Bernardo WM
    J Bras Pneumol; 2022; 48(1):e20210393. PubMed ID: 35137874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
    WHO Solidarity Trial Consortium
    Lancet; 2022 May; 399(10339):1941-1953. PubMed ID: 35512728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis.
    Singh S; Khera D; Chugh A; Khera PS; Chugh VK
    BMJ Open; 2021 Jun; 11(6):e048416. PubMed ID: 34168031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compassionate Use of Remdesivir for Patients with Severe Covid-19.
    Grein J; Ohmagari N; Shin D; Diaz G; Asperges E; Castagna A; Feldt T; Green G; Green ML; Lescure FX; Nicastri E; Oda R; Yo K; Quiros-Roldan E; Studemeister A; Redinski J; Ahmed S; Bernett J; Chelliah D; Chen D; Chihara S; Cohen SH; Cunningham J; D'Arminio Monforte A; Ismail S; Kato H; Lapadula G; L'Her E; Maeno T; Majumder S; Massari M; Mora-Rillo M; Mutoh Y; Nguyen D; Verweij E; Zoufaly A; Osinusi AO; DeZure A; Zhao Y; Zhong L; Chokkalingam A; Elboudwarej E; Telep L; Timbs L; Henne I; Sellers S; Cao H; Tan SK; Winterbourne L; Desai P; Mera R; Gaggar A; Myers RP; Brainard DM; Childs R; Flanigan T
    N Engl J Med; 2020 Jun; 382(24):2327-2336. PubMed ID: 32275812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis.
    Rezagholizadeh A; Khiali S; Sarbakhsh P; Entezari-Maleki T
    Eur J Pharmacol; 2021 Apr; 897():173926. PubMed ID: 33549577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.